| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Stablecoin Development Corp
13D/A
Amendment 6
SDEV · 66987P508
|
46.6% |
7/24/2026
Event 7/18/2026
|
|||
| Framework Ventures IV L.P. | 46.6% | ||||
| Framework Ventures Management LLC | 46.6% | ||||
| Framework Ventures IV GP LLC | 46.6% | ||||
| Spencer Vance | 46.6% | ||||
| Anderson Michael Ernest | 46.6% | ||||
|
Stablecoin Development Corp
13D/A
Amendment 5
SDEV · 66987P508
|
45.9% |
6/17/2026
Event 6/15/2026
|
|||
| Framework Ventures IV L.P. | 45.9% | ||||
| Framework Ventures Management LLC | 45.9% | ||||
| Framework Ventures IV GP LLC | 45.9% | ||||
| Spencer Vance | 45.9% | ||||
| Anderson Michael Ernest | 45.9% | ||||
|
Stablecoin Development Corp
13D/A
Amendment 4
SDEV · 66987P508
|
46.4% |
5/19/2026
Event 5/17/2026
|
|||
| Framework Ventures IV L.P. | 46.4% | ||||
| Framework Ventures Management LLC | 46.4% | ||||
| Framework Ventures IV GP LLC | 46.4% | ||||
| Vance Spencer | 46.4% | ||||
| Michael Ernest Anderson | 46.4% | ||||
|
Stablecoin Development Corp
13D/A
Amendment 3
SDEV · 66987P508
|
44.5% |
4/30/2026
Event 4/29/2026
|
|||
| Framework Ventures IV L.P. | 44.5% | ||||
| Framework Ventures Management LLC | 44.5% | ||||
| Framework Ventures IV GP LLC | 44.5% | ||||
| Spencer Vance | 44.5% | ||||
| Anderson Michael Ernest | 44.5% | ||||
|
Better Home & Finance Holding Co
13G
BETR · 08774B508
|
12.4% |
4/6/2026
Event 3/31/2026
|
|||
| Framework Ventures IV L.P. | 9.0% | ||||
| Framework Ventures Management LLC | 9.0% | ||||
| Framework Ventures IV GP LLC | 9.0% | ||||
| Spencer Vance | 12.4% | ||||
| Anderson Michael Ernest | 11.3% | ||||
| Framework Labs, Inc. | 2.3% | ||||
|
NovaBay Pharmaceuticals, Inc.
13D/A
Amendment 2
NBY · 66987P409
|
45.0% |
1/21/2026
Event 1/16/2026
|
|||
| Framework Ventures IV L.P. | 45.0% | ||||
| Framework Ventures Management LLC | 45.0% | ||||
| Framework Ventures IV GP LLC | 45.0% | ||||
| Spencer Vance | 45.0% | ||||
| Anderson Michael Ernest | 45.0% | ||||
|
NovaBay Pharmaceuticals, Inc.
13D/A
Amendment 1
NBY · 66987P409
|
45.1% |
10/20/2025
Event 10/16/2025
|
|||
| Framework Ventures IV L.P. | 45.1% | ||||
| Framework Ventures Management LLC | 45.1% | ||||
| Framework Ventures IV GP LLC | 45.1% | ||||
| Vance Spencer | 45.1% | ||||
| Michael Ernest Anderson | 45.1% | ||||
|
NovaBay Pharmaceuticals, Inc.
13D
NBY · 66987P409
|
16.2% |
10/15/2025
Event 10/9/2025
|
|||
| Framework Ventures IV L.P. | 16.2% | ||||
| Framework Ventures Management LLC | 16.2% | ||||
| Framework Ventures IV GP LLC | 16.2% | ||||
| Vance Spencer | 16.2% | ||||
| Michael Ernest Anderson | 16.2% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.